VolitionRx Limited director Mickie Henshall will not stand for re-election at the 2026 Annual Meeting, prompting the Board to reduce its size from eight to seven directors.
Key takeaways
Mickie Henshall notified the Board on May 12, 2026, of her decision not to stand for re-election at the 2026 Annual Meeting.
Ms. Henshall has served on the Board since August 2022.
Decision not to stand for re-election did not involve any disagreement with the Company on operations, policies or practices.
Board will reduce its size from eight to seven directors, effective immediately prior to the 2026 Annual Meeting.